Bionano Genomics (MEX:BNGO) Total Stockholders Equity : MXN985.8 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Bionano Genomics Total Stockholders Equity?

Bionano Genomics's Total Stockholders Equity for the quarter that ended in Mar. 2025 was MXN985.8 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Bionano Genomics's Book Value per Share for the quarter that ended in Mar. 2025 was MXN317.91. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Bionano Genomics's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.38.

Bionano Genomics Total Stockholders Equity Historical Data

The historical data trend for Bionano Genomics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics Total Stockholders Equity Chart

Bionano Genomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

697.85

6,915.64

4,862.26

1,632.19

737.77

Bionano Genomics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															1,373.69	1,471.78	962.23	737.77	985.84

Bionano Genomics (MEX:BNGO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Bionano Genomics's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(985.84	-	0)	/	3.101
	=	317.91

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Bionano Genomics's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(304.602	+	72.136)	/	985.84
	=	0.38

Bionano Genomics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionano Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (MEX:BNGO) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BNGO:USA

Address

9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://www.bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.